- GLP-1 receptor agonist drugs such as tirzepatide and semaglutide may be beneficial in reducing post-surgery complications in people with diabetes.
- Patients taking these medications had lower rates of hospital readmission, fewer wound re-openings, and reduced odds of blood clots at the surgical site.
- The study drew from medical records on 35,020 operations in patients with diabetes.
- Risks of bleeding and infections were similar regardless of whether patients were taking GLP-1 drugs.
- The study does not definitively prove that GLP-1 drugs prevented complications but suggests potential benefits.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
